Biosimilars Market

R&D

Pioneering access to biosimilars is crucial for strengthening health equity by providing affordable, life-changing therapies to patients worldwide.

Partner Content

Biosimilars Market will surpass USD 69 billion by 2025

News

ITM's first attempt to score FDA approval for one of its radiopharma therapies has been knocked back by the agency.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.